Global Biochips Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
The Global Biochips Market is expected to grow from USD 21,869.85 Million in 2018 to USD 78,967.98 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 20.13%.
The positioning of the Global Biochips Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Biochips Market including are Abbott Laboratories, Agilent Technologies, Inc., Fluidigm Corporation, Illumina, Inc., Perkinelmer, Inc., Bio-Rad Laboratories Inc., Cepheid Inc., GE Healthcare, Roche Diagnostics, and Thermo Fisher Scientific, Inc..
On the basis of Fabrication Technology, the Global Biochips Market is studied across Microarrays and Microfluidics.
On the basis of Type, the Global Biochips Market is studied across Arrays, DNA Chips, Lab-On-A-Chip, and Protein Chips.
On the basis of Application, the Global Biochips Market is studied across Agricultural Biotechnology, Cancer Diagnosis & Treatment, Clinical Diagnostics, DNA Chip Applications, Diagnostics, Drug Discovery, Expression Profiling, Gene Expression, Genomics, High-Throughput Screening, IVD & POC, Proteomics, and SNP Genotyping.
On the basis of End User, the Global Biochips Market is studied across Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Diagnostics Centers.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Biochips Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Biochips Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Biochips Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Biochips Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Biochips Market
The report answers questions such as:
1. What is the market size of Biochips market in the Global?
2. What are the factors that affect the growth in the Global Biochips Market over the forecast period?
3. What is the competitive position in the Global Biochips Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Biochips Market?
5. What are the opportunities in the Global Biochips Market?
6. What are the modes of entering the Global Biochips Market?
The positioning of the Global Biochips Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Biochips Market including are Abbott Laboratories, Agilent Technologies, Inc., Fluidigm Corporation, Illumina, Inc., Perkinelmer, Inc., Bio-Rad Laboratories Inc., Cepheid Inc., GE Healthcare, Roche Diagnostics, and Thermo Fisher Scientific, Inc..
On the basis of Fabrication Technology, the Global Biochips Market is studied across Microarrays and Microfluidics.
On the basis of Type, the Global Biochips Market is studied across Arrays, DNA Chips, Lab-On-A-Chip, and Protein Chips.
On the basis of Application, the Global Biochips Market is studied across Agricultural Biotechnology, Cancer Diagnosis & Treatment, Clinical Diagnostics, DNA Chip Applications, Diagnostics, Drug Discovery, Expression Profiling, Gene Expression, Genomics, High-Throughput Screening, IVD & POC, Proteomics, and SNP Genotyping.
On the basis of End User, the Global Biochips Market is studied across Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Diagnostics Centers.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Biochips Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Biochips Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Biochips Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Biochips Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Biochips Market
The report answers questions such as:
1. What is the market size of Biochips market in the Global?
2. What are the factors that affect the growth in the Global Biochips Market over the forecast period?
3. What is the competitive position in the Global Biochips Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Biochips Market?
5. What are the opportunities in the Global Biochips Market?
6. What are the modes of entering the Global Biochips Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. RESEARCH & FORECASTING
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. EXECUTIVE SUMMARY
3.1. Outlook in the Biochips Market
3.2. Opportunities in the Biochips Market
4. PREMIUM INSIGHT
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increasing incidences of life-threatening disorder and rise in geriatric population
4.2.1.2. Demand of personalized adoption owing to increase adoption
4.2.1.3. Large number of biochips applications
4.2.2. Restraints
4.2.2.1. Limited awareness in developing economies
4.2.2.2. Loosely defined regulatory guidelines
4.2.3. Opportunities
4.2.3.1. Potential in untapped developed regions
4.2.3.2. Safe and economical alternative to animal testing
4.2.4. Challenges
4.2.4.1. High cost associated with biochips
4.2.4.2. Complexity associated with the biological system
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
4.4.1. Technology Advancements
4.4.2. Impact Analysis
5. GLOBAL BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Microarrays
5.4. Microfluidics
6. GLOBAL BIOCHIPS MARKET, BY TYPE
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Arrays
6.3.1. Cell Arrays
6.3.2. Tissue Arrays
6.4. DNA Chips
6.5. Lab-On-A-Chip
6.6. Protein Chips
7. GLOBAL BIOCHIPS MARKET, BY APPLICATION
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Agricultural Biotechnology
7.4. Cancer Diagnosis & Treatment
7.5. Clinical Diagnostics
7.6. DNA Chip Applications
7.7. Diagnostics
7.8. Drug Discovery
7.9. Expression Profiling
7.10. Gene Expression
7.11. Genomics
7.12. High-Throughput Screening
7.13. IVD & POC
7.14. Proteomics
7.15. SNP Genotyping
8. GLOBAL BIOCHIPS MARKET, BY END USER
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Academic & Research Institutes
8.4. Biotechnology & Pharmaceutical Companies
8.5. Hospitals & Diagnostics Centers
9. GLOBAL BIOCHIPS MARKET, BY GEOGRAPHY
9.1. Overview
9.2. Market Sizing & Forecasting
9.3. Americas
9.3.1. Overview
9.3.2. Market Sizing & Forecasting
9.3.3. Argentina
9.3.4. Brazil
9.3.5. Canada
9.3.6. Mexico
9.3.7. United States
9.4. Asia-Pacific
9.4.1. Overview
9.4.2. Market Sizing & Forecasting
9.4.3. Australia
9.4.4. China
9.4.5. India
9.4.6. Japan
9.5. Europe, Middle East & Africa
9.5.1. Overview
9.5.2. Market Sizing & Forecasting
9.5.3. France
9.5.4. Germany
9.5.5. Italy
9.5.6. Spain
9.5.7. United Kingdom
10. COMPETITIVE LANDSCAPE
10.1. 360iResearch FPNV Positioning Matrix for Global Biochips Market
10.2. Market Vendor Ranking Analysis for Global Biochips Market
10.3. Competitive News Feed Analysis for Global Biochips Market
11. COMPANY USABILITY PROFILES
11.1. Abbott Laboratories
11.1.1. Overview
11.1.2. Strategy
11.1.3. SWOT
11.2. Agilent Technologies, Inc.
11.2.1. Overview
11.2.2. Strategy
11.2.3. SWOT
11.3. Fluidigm Corporation
11.3.1. Overview
11.3.2. Strategy
11.3.3. SWOT
11.4. Illumina, Inc.
11.4.1. Overview
11.4.2. Strategy
11.4.3. SWOT
11.5. Perkinelmer, Inc.
11.5.1. Overview
11.5.2. Strategy
11.5.3. SWOT
11.6. Bio-Rad Laboratories Inc.
11.7. Cepheid Inc.
11.8. GE Healthcare
11.9. Roche Diagnostics
11.10. Thermo Fisher Scientific, Inc.
12. APPENDIX
12.1. Discussion Guide
12.2. Top Reports
12.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.3. Author Details
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. RESEARCH & FORECASTING
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. EXECUTIVE SUMMARY
3.1. Outlook in the Biochips Market
3.2. Opportunities in the Biochips Market
4. PREMIUM INSIGHT
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increasing incidences of life-threatening disorder and rise in geriatric population
4.2.1.2. Demand of personalized adoption owing to increase adoption
4.2.1.3. Large number of biochips applications
4.2.2. Restraints
4.2.2.1. Limited awareness in developing economies
4.2.2.2. Loosely defined regulatory guidelines
4.2.3. Opportunities
4.2.3.1. Potential in untapped developed regions
4.2.3.2. Safe and economical alternative to animal testing
4.2.4. Challenges
4.2.4.1. High cost associated with biochips
4.2.4.2. Complexity associated with the biological system
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
4.4.1. Technology Advancements
4.4.2. Impact Analysis
5. GLOBAL BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Microarrays
5.4. Microfluidics
6. GLOBAL BIOCHIPS MARKET, BY TYPE
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Arrays
6.3.1. Cell Arrays
6.3.2. Tissue Arrays
6.4. DNA Chips
6.5. Lab-On-A-Chip
6.6. Protein Chips
7. GLOBAL BIOCHIPS MARKET, BY APPLICATION
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Agricultural Biotechnology
7.4. Cancer Diagnosis & Treatment
7.5. Clinical Diagnostics
7.6. DNA Chip Applications
7.7. Diagnostics
7.8. Drug Discovery
7.9. Expression Profiling
7.10. Gene Expression
7.11. Genomics
7.12. High-Throughput Screening
7.13. IVD & POC
7.14. Proteomics
7.15. SNP Genotyping
8. GLOBAL BIOCHIPS MARKET, BY END USER
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Academic & Research Institutes
8.4. Biotechnology & Pharmaceutical Companies
8.5. Hospitals & Diagnostics Centers
9. GLOBAL BIOCHIPS MARKET, BY GEOGRAPHY
9.1. Overview
9.2. Market Sizing & Forecasting
9.3. Americas
9.3.1. Overview
9.3.2. Market Sizing & Forecasting
9.3.3. Argentina
9.3.4. Brazil
9.3.5. Canada
9.3.6. Mexico
9.3.7. United States
9.4. Asia-Pacific
9.4.1. Overview
9.4.2. Market Sizing & Forecasting
9.4.3. Australia
9.4.4. China
9.4.5. India
9.4.6. Japan
9.5. Europe, Middle East & Africa
9.5.1. Overview
9.5.2. Market Sizing & Forecasting
9.5.3. France
9.5.4. Germany
9.5.5. Italy
9.5.6. Spain
9.5.7. United Kingdom
10. COMPETITIVE LANDSCAPE
10.1. 360iResearch FPNV Positioning Matrix for Global Biochips Market
10.2. Market Vendor Ranking Analysis for Global Biochips Market
10.3. Competitive News Feed Analysis for Global Biochips Market
11. COMPANY USABILITY PROFILES
11.1. Abbott Laboratories
11.1.1. Overview
11.1.2. Strategy
11.1.3. SWOT
11.2. Agilent Technologies, Inc.
11.2.1. Overview
11.2.2. Strategy
11.2.3. SWOT
11.3. Fluidigm Corporation
11.3.1. Overview
11.3.2. Strategy
11.3.3. SWOT
11.4. Illumina, Inc.
11.4.1. Overview
11.4.2. Strategy
11.4.3. SWOT
11.5. Perkinelmer, Inc.
11.5.1. Overview
11.5.2. Strategy
11.5.3. SWOT
11.6. Bio-Rad Laboratories Inc.
11.7. Cepheid Inc.
11.8. GE Healthcare
11.9. Roche Diagnostics
11.10. Thermo Fisher Scientific, Inc.
12. APPENDIX
12.1. Discussion Guide
12.2. Top Reports
12.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.3. Author Details
